Abeona Therapeutics (ABEO) Non Operating Interest Expenses (2011 - 2026)

Abeona Therapeutics' Non Operating Interest Expenses history runs 4 years deep, the most recent figure standing at $2000.0 for Q4 2018.

• In Q4 2018, Non Operating Interest Expenses rose 100.0% year-over-year to $2000.0; the TTM figure through Jun 2019 stood at $5000.0 (down 44.44% YoY), while the FY2018 annual figure was $11000.0, up 37.5% from the prior year.
• Non Operating Interest Expenses for Q4 2018 stood at $2000.0, down from $3000.0 in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $3000.0 in Q2 2017, with the low at $1000.0 in Q3 2015.
• The 4-year median for Non Operating Interest Expenses is $2000.0 (2015), against an average of $2000.0.
• The sharpest annual moves came in 2016 and 2017: Non Operating Interest Expenses plunged 50.0% in 2016, then jumped 200.0% in 2017.
• Abeona Therapeutics' Non Operating Interest Expenses stood at $2000.0 in 2015, then changed by 0.0% to $2000.0 in 2016, then slumped by 50.0% to $1000.0 in 2017, then surged by 100.0% to $2000.0 in 2018.
• Business Quant data shows ABEO's Non Operating Interest Expenses at $2000.0 in Q4 2018, $3000.0 in Q3 2018, and $3000.0 in Q2 2018.